Early Versus Late Administration of P2Y12 Inhibitors in Non-ST Segment Elevation Myocardial Infarction and Delayed Cardiac Catheterization

被引:0
|
作者
Lycouras, Maggie M. [1 ]
Clark, Collin M. [1 ,2 ]
Mills, Kevin [1 ]
Gupta, Aman [3 ]
Chilbert, Maya R. [1 ,2 ]
机构
[1] Buffalo Gen Med Ctr, Pharm Dept, Buffalo, NY USA
[2] Univ Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[3] Buffalo Gen Med Ctr, Cardiol Dept, Buffalo, NY USA
关键词
P2Y(12) inhibitors; NSTEMI; GP IIb; IIIa inhibitor; bleeding; troponin; METAANALYSIS; ANGIOGRAPHY; ANTAGONISTS; DEFINITION; RISK;
D O I
10.1097/FJC.0000000000001302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regardless of early invasive or ischemia-guided approaches to non-ST segment elevation myocardial infarction (NSTEMI) management, P2Y(12) inhibitors remain the backbone in therapy. The ideal timing of administration remains unclear. The purpose of this study was to determine the safety and effectiveness of early versus late administration of P2Y(12) inhibitors in patients presenting with an NSTEMI who go to the catheterization laboratory beyond 24 hours from presentation. We performed a single center, retrospective cohort study. Patients were classified into groups depending on whether they received early versus late administration of a P2Y(12) inhibitor. The primary outcome was the rate of major and clinically relevant, nonmajor bleeding (CRNMB). Secondary outcomes included troponin peak and length of stay after cardiac catheterization. Of the 121 patients included, 53 patients were in the early and 68 patients were in the late group. The number of bleeding events were similar between both groups (P = 1.00). There were 3 (5.7%) major bleeding events in the early group and 5 (7.4%) bleeding events in the late group. There were 5 (9.4%) CRNMB events in the early group and 6 (8.8%) CRNMB events in the late group. There was a significant difference in troponin peak, 4.56 ng/mL in the early group and 1.77 ng/mL in the late group (P = 0.02). The rate of bleeding did not differ between patients who received early or late administration of P2Y(12) inhibitors for NSTEMI management who undergo delayed cardiac catheterization.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 50 条
  • [1] Bending the Reluctance of No Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction
    Koliastasis, Leonidas
    Doundoulakis, Ioannis
    Xaplanteris, Panagiotis
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (06)
  • [2] Early P2Y12 inhibition in ST-segment elevation myocardial infarction: Bridging the gap
    Alexopoulos, Dimitrios
    Bhatt, Deepak L.
    Hamm, Chistian W.
    Steg, Philippe Gabriel
    Stone, Gregg W.
    AMERICAN HEART JOURNAL, 2015, 170 (01) : 3 - 12
  • [3] EFFECT OF EARLY VERSUS DELAYED PERCUTANEOUS REVASCULARIZATION IN NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION WITH CARDIOGENIC SHOCK
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Shetty, Suchith
    Aronow, Wilbert
    Cooper, Howard A.
    Panza, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1224 - 1224
  • [4] EARLY VERSUS DELAYED INVASIVE INTERVENTION FOR NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: A NATIONWIDE ANALYSIS
    Dominguez, Abel Casso
    Lemor, Alejandro
    Lee, Shawn
    Herrera, Yasmin I.
    Leal, Daniel
    El-Hayek, Georges
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 219 - 219
  • [5] P2Y12 inhibitor loading dose before catheterization in ST-segment elevation myocardial infarction: Is this the best strategy?
    Moura Guedes, Joao Pedro
    Marques, Nuno
    Azevedo, Pedro
    Mota, Teresa
    Bispo, Joao
    Fernandes, Raquel
    Costa, Hugo
    Vinhas, Hugo
    Mimoso, Jorge
    de Jesus, Ilidio
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (10) : 553 - 561
  • [6] The Conundrum of Platelet P2Y12 Inhibition in ST-Segment Elevation Myocardial Infarction
    Rollini, Fabiana
    Franchi, Francesco
    CIRCULATION JOURNAL, 2016, 80 (12) : 2429 - 2431
  • [7] REPLY: Observational Data Fueling the Debate on Preloading P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction
    Rohla, Miklos
    Raber, Lorenz
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (06) : 823 - 824
  • [8] Effects of P2Y12 Receptor Inhibition in Patients With ST-Segment Elevation Myocardial Infarction
    Alexopoulos, Dimitrios
    Xanthopoulou, Ioanna
    Goudevenos, John
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (12): : 2064 - 2069
  • [9] After COACT trial-new perspectives for the management of non-ST elevation myocardial infarction: early versus late cardiac catheterization post cardiac arrest
    Maturana, Miguel A.
    Clinton, Charles E.
    Caballero-Cummings, Selene
    Cave, Brandon
    Khan, Amal
    Nanda, Amit
    Ardeshna, Devarshi
    Raja, Joel
    Khouzam, Rami N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [10] Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and Frailty
    Ko, Darae
    Pande, Ashvin
    Lin, Kueiyu Joshua
    Cervone, Alexander
    Bessette, Lily G.
    Lee, Su Been
    Cheng, Susan
    Glynn, Robert J.
    Kim, Dae Hyun
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 207 : 245 - 252